Can a Single Dose of DMT Safely and Rapidly Treat Depression?

Posted: April 5, 2026

Key Takeaways

•A new 2026 study shows that a single dose of the psychedelic DMT quickly reduced symptoms of depression in people with Major Depressive Disorder (MDD).

•The positive effects were felt just one week after treatment. For some people, these effects lasted for up to three months.

•Another 2026 study on mice found that DMT helps grow new brain cells. This process is called neurogenesis. It may reverse brain damage caused by long-term stress.

•DMT seems to work by increasing the brain’s ability to change and form new connections. This is known as brain plasticity. This is different from how common antidepressants work.

•This research is exciting, but it is still early. More studies are needed to know if DMT is a safe and effective treatment for most people.

Introduction

For many years, the main treatment for depression has been antidepressant pills. These drugs, like SSRIs, work by changing the levels of chemicals in the brain. They have helped many people. But for others, they don’t work well or cause bad side effects.

This has led scientists to look for new ways to treat depression. They have started to study psychedelic drugs again. A new study in the journal Nature Medicine looked at a psychedelic called DMT. It found that a single dose could give fast and lasting relief to people with depression (1). Other research on mice shows that DMT may even repair the brain (2). This new science offers a whole new way to think about healing from depression.

How Does a Single Dose of DMT Affect Depression?

A recent study looked at the effects of a short-acting, lab-made version of DMT. The study was a Phase IIa trial. This means it was focused on safety and finding the right dose. The study included people with moderate to severe depression. Some people got a dose of DMT, while others got a placebo (a dose with no drug in it). The results were impressive.

People who got DMT had a big drop in their depression scores. These scores were measured with a tool called the MADRS (Montgomery-Åsberg Depression Rating Scale). The improvements happened fast, within just one week. And for many, the good effects lasted. Some people still felt better three months later (1). This is very different from regular antidepressants, which you have to take every day. Other studies have also noted that psychedelics like psilocybin and DMT can work very quickly to fight depression (3).

How Does DMT Work in the Brain?

Scientists believe DMT works by helping the brain change and heal itself. This is called neuroplasticity. It’s the brain’s ability to make new connections between brain cells.

A 2026 study in the journal Translational Psychiatry showed how this might work. Scientists studied mice that were under a lot of stress. The stress caused the mice to show signs of depression. They lost interest in things they usually enjoyed. But a single dose of DMT changed that. The mice started acting like their old selves again (2).

The study found that DMT caused the growth of new brain cells. This is a process called neurogenesis. It happened in a part of the brain called the hippocampus. The hippocampus is important for learning, memory, and mood. Stress can damage this part of the brain. The DMT treatment seemed to repair that damage. This suggests that DMT doesn’t just cover up symptoms. It may help heal the brain itself. This is similar to how other psychedelics like psilocybin are thought to work (4, 5).

Is DMT a Safe Treatment for Depression?

Safety is the most important thing when it comes to new treatments. This is especially true for a powerful drug like DMT. In the study, DMT was found to be mostly safe. The psychedelic experience, or “trip,” was strong but short. It only lasted about 20 to 30 minutes. This is much shorter than a psilocybin trip, which can last for hours. The side effects were mostly mild. They included things like headaches, feeling sick, and dizziness (1).

It is very important to know that these studies happen in a safe, controlled setting. Patients get support from trained therapists. This is not the same as using DMT for fun. The therapy setting is designed to keep people safe and help them have a good experience. Before DMT can be a common treatment, more research is needed to create clear safety rules. If you are thinking about these treatments, it is vital to work with a trained professional. This helps reduce risks and is a key part of the Psychedelic Integration services I offer.

What Are the Next Steps for DMT Research?

The good results from these first studies are just the beginning. The company that makes this form of DMT is planning a larger study. This new study will include more people from different countries. It will help confirm if DMT is truly safe and effective for depression (6).

Scientists will also keep studying how DMT works in the brain. The more we understand how it helps the brain heal, the better we can make the treatments. It is an exciting time, but we must be patient. We need more research before DMT becomes a normal treatment. If you are dealing with depression that hasn’t gotten better with other treatments, there is still hope. Exploring proven options like Trauma-Informed Therapy can help you now.

Take the Next Step with Serenity Professional Counseling

The world of mental health is changing. New and hopeful treatments are being discovered. If you are dealing with depression and want to learn about the latest, science-backed ways to heal, you are not alone. At Serenity Professional Counseling, I offer a safe and supportive space to help you on your path. To learn more, please contact me today.

About the Author

This article was written by Jeff Jones, a Licensed Professional Counselor (LPC) in Texas in practice since 1999. He is a 2024 graduate of the CIIS Center for Psychedelic Therapies and Research program. With a compassionate and evidence-based approach, he helps clients navigate life's challenges and find a path toward healing.

Disclaimer

This article is for informational purposes only and does not constitute medical advice. The use of psychedelic substances is illegal in many jurisdictions and can carry significant risks. The information presented here is based on scientific research conducted in controlled, clinical settings. Please consult with a qualified healthcare professional before making any decisions about your treatment.

References

1.Erritzoe, D., et al. (2026). A phase IIa randomized, placebo-controlled trial of single-dose DMT (SPL026) for major depressive disorder. Nature Medicine. https://www.nature.com/articles/s41591-025-04154-z

2.Dominguez-Clave, E., et al. (2026 ). Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model. Translational Psychiatry. https://www.nature.com/articles/s41398-026-03852-7

3.Ko, K., et al. (2023 ). Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 322, 194-204. https://www.sciencedirect.com/science/article/abs/pii/S0165032722011818

4.Goodwin, G. M., et al. (2022 ). Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine, 387(18), 1637–1648. https://www.nejm.org/doi/full/10.1056/NEJMoa2206443

5.López-Giménez, J. F., & González-Maeso, J. (2018 ). Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways. Current topics in behavioral neurosciences, 36, 45–73. https://link.springer.com/chapter/10.1007/7854_2017_478

6.Cybin. (2023 ). Cybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics. [Press Release]. Business Wire. https://www.businesswire.com/news/home/20231022071953/en/Cybin-Completes-Acquisition-of-Small-Pharma-Inc.-to-Create-International-Clinical-stage-Leader-in-Novel-Psychedelic-Therapeutics